The New England journal of medicine, 2019-05, Vol.380 (21), p.2020-2030
2019
Details
- Autor(en) / Beteiligte
- Titel
- Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthma
- Ist Teil von
- The New England journal of medicine, 2019-05, Vol.380 (21), p.2020-2030
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2019
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In this trial, patients with mild asthma used albuterol alone as needed, inhaled budesonide maintenance therapy plus albuterol as needed, or an inhaler containing both budesonide and formoterol as needed for asthma symptoms. There were fewer exacerbations in both groups in which treatment included budesonide.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa1901963Titel-ID: cdi_proquest_miscellaneous_2232073288
- Format
- –
- Schlagworte
- Administration, Inhalation, Adrenergic beta-2 Receptor Agonists - administration & dosage, Adrenergic beta-2 Receptor Agonists - adverse effects, Adult, Aged, Albuterol - administration & dosage, Albuterol - adverse effects, Analysis, Asthma, Asthma - drug therapy, Bronchodilator Agents - administration & dosage, Bronchodilator Agents - adverse effects, Budesonide, Budesonide - administration & dosage, Budesonide - adverse effects, Clinical medicine, Clinical trials, Control, Dosage and administration, Drug therapy, Drug Therapy, Combination, Evidence-based medicine, Female, Formoterol, Formoterol Fumarate - administration & dosage, Formoterol Fumarate - adverse effects, Humans, Inhalation, Inhalers, Male, Medical research, Metered Dose Inhalers, Middle Aged, Patients